GSRIX
Price
$13.03
Change
-$0.04 (-0.31%)
Updated
Jul 13 closing price
Net Assets
408.34M
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

GSRIX vs VSTSX

GSRIX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
GSRIX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSRIX is a Buy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. GSRIX (408M). GSRIX pays higher dividends than VSTSX: GSRIX (1.33) vs VSTSX (1.07). GSRIX was incepted earlier than VSTSX: GSRIX (14 years) vs VSTSX (10 years). GSRIX (1.04) is less costly to investors than VSTSX (0.01). GSRIX is a more actively managed with annual turnover of: 35.00 vs. VSTSX (3.00). GSRIX has a lower initial minimum investment than VSTSX: GSRIX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. GSRIX (4.59). VSTSX return over 5 years is better than : 66.56 vs. GSRIX (2.78).
GSRIXVSTSXGSRIX / VSTSX
Total Expense Ratio0.760.017,600%
Annual Report Gross Expense Ratio1.040.0110,400%
Fund Existence14 years10 years-
Gain YTD12.36211.205110%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets408M2.3T0%
Annual Yield % from dividends1.331.07124%
Returns for 1 year4.5921.4821%
Returns for 3 years12.6767.0619%
Returns for 5 years2.7866.564%
Returns for 10 years-25.49239.53-11%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I